Resolved (unanimously) to grant the application for planning permission in accordance with the officer recommendation, for the reasons set out in the officer report, and subject to the conditions recommended by the officers subject to the amendments made to conditions 17 and 18(iv), authority was delegated to officers to compose appropriate substitute wording for condition 18( i ).
Word for word from the decision Cambridge published for this meeting.Source: democracy.cambridge.gov.uk
Application 16/1078/OUT Agenda Number Item Date Received 10th June 2016 Officer Tony Collins Target Date 9th September 2016 Ward Queen Ediths Site Plot 9 Cambridge Biomedical Campus Francis Crick Avenue Cambridge Proposal Outline Application with all matters reserved for up to 14,193 sqm (excluding plant areas) of biomedical and biotech research and development (Use Class B1(b)); landscaping; car and cycle parking areas and all other associated infrastructure. Applicant University of Cambridge Estate Management, Greenwich House Madingley Road CB3 0TX
SUMMARY The development accords with the Development Plan for the following reasons:
The principle of this use is consistent with Paragraph 19 of the Framework, and with policies and site allocations in both the 2006 Cambridge Local Plan and the Cambridge Local Plan 2014 Proposed Submission.
The submitted parameter plans will ensure that any future building will sit harmoniously within the context of the wider Biomedical Campus. The proposed use will not have any unacceptable impact on the highway network.
The proposal causes no conflict with the drainage strategy already approved for the wider Biomedical Campus site.
RECOMMENDATION APPROVAL 1.0 SITE DESCRIPTION/AREA CONTEXT
1.1Plot 9 is a rectangular site of 0.77ha. It lies within the wide area to the south and west of Addenbrooke’s hospital granted outline permission for clinical and research floorspace under 06/0796/OUT, and usually referred to as the Cambridge Biomedical Campus (CBC) Phase 1. The outline permission was subsequently amended under 14/2094/S73, and 14/1691/S73. Planning Committee resolved on 3rd August 2016 to grant outline permission for Phase 2 of the CBC to the south of Dame Mary Archer Way.
1.2The Plot 9 site lies towards the south-west corner of the Phase 1 outline permission site, east of the Cambridge-London railway line and west of Francis Crick Avenue, close to the point at which the Addenbrooke’s link road crosses the railway. It was formerly agricultural land, but it has been cleared, and is currently being used by contractors in connection with the archaeological investigation on the adjoining Plot 8 site to the south.
1.3The site is allocated for mixed uses, primarily clinical, biomedical and biotech research and development uses, higher education and sui generis research institutes under policy 9.5 in the Cambridge Local Plan (2006). This mixed use allocation is maintained under policy 16 of the Cambridge Local Plan 2014 Proposed Submission.
2.0THE PROPOSAL
2.1The CBC Phase 1 outline approval given under 06/0796/OUT essentially granted permission for 60,000m2 of clinical research and treatment space for Addenbrooke's, and 115,000m2 for biomedical and biotech research and development (and support services).
2.2Since the granting of that outline consent in 2009, reserved matters approval has been granted and construction is now completed or well advanced on a number of high-profile projects within CBC, including the new MRC Laboratory of Molecular Biology LMB (07/0651/FUL), the new Papworth Hospital (14/1411/REM), and the new Global R&D Centre and new Corporate Headquarters for AstraZeneca (14/1633/REM). In addition, at Planning Committee on 3rd August 2016, an application for biomedical and biotech research and development use on Plot 8, immediately to the south of the present application site, was approved. As the table below shows, the total research space given reserved matters approval in these buildings is now, at 94,000m2, over 80% of the total floorspace of this type sanctioned under the original outline permission
Biomedical and Biotech research and development floorspace permitted (B1(b)) Outline permission (06/0796/OUT 115,000 LMB Building (07/0651/FUL) 25,209 New Papworth Hospital (14/1411/REM) -
AstraZeneca (14/1633/REM) 59,821
Plot 8 Bellatrix (16/0653/REM) 9,033
Total Detailed Floorspace Approved 94,063
Read every report as text, not just the decision
Pro opens the officer report behind each decision, searchable and quotable, across every council we cover.
We use a cookie to keep you signed in and run your free-paper allowance, and an optional one to count visits. You can accept all, or choose. Privacy & cookies
Necessary
Keeps you signed in and runs your free-paper allowance. Always on.
Always on
Analytics
Counts visits and which pages are used. First-party only, no advertising, never shared.